Ftse Mib
32.623,99
-2,93%
DAX
18.003,72
-1,42%
S&P 500
5.421,56
-0,22%
NASDAQ
17.658,84
-0,05%
Bitcoin
66.934,81
0,23%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Assembly Biosciences Inc (ASMB) Assembly Biosciences Inc (ASMB) Notizie

Assembly Biosciences Inc

ASMB
15,1466
0,0166 (0,11%)
Ultimo aggiornamento: 17:16:06
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/6/202414:00GLOBEAssembly Biosciences Doses First Participant in Phase 1a/b..
05/6/202414:00GLOBEAssembly Biosciences Presents New Data Highlighting..
03/6/202422:05EDGAR2Form 8-K - Current report
30/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202414:00GLOBEAssembly Biosciences to Present Data at Upcoming..
08/5/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:10EDGAR2Form 8-K - Current report
08/5/202422:05GLOBEAssembly Biosciences Reports First Quarter 2024 Financial..
28/3/202421:05GLOBEAssembly Biosciences Reports Fourth Quarter and Year End..
08/2/202414:00GLOBEAssembly Biosciences Announces Effective Date of Reverse..
02/2/202422:05EDGAR2Form 8-K - Current report
19/1/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:05EDGAR2Form 8-K - Current report
04/1/202414:00GLOBEAssembly Biosciences Provides Anticipated Development..
21/12/202322:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
21/12/202322:01EDGAR2Form DEF 14A - Other definitive proxy statements
11/12/202322:10EDGAR2Form PRE 14A - Other preliminary proxy statements
11/12/202322:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/12/202322:05EDGAR2Form 8-K - Current report
22/11/202322:12EDGAR2Form SC 13D/A - General statement of acquisition of..
22/11/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202322:05GLOBEAssembly Biosciences Reports Inducement Grant Under Nasdaq..
10/11/202314:00GLOBEAssembly Biosciences Presents New Data Highlighting Viral..
08/11/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:10EDGAR2Form 8-K - Current report
08/11/202322:05GLOBEAssembly Biosciences Reports Third Quarter 2023 Financial..
08/11/202314:00GLOBEAssembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief..
03/11/202321:05EDGAR2Form SC 13D/A - General statement of acquisition of..
31/10/202321:19EDGAR2Form SC 13D - General statement of acquisition of beneficial..
31/10/202317:38EDGAR2Form 3 - Initial statement of beneficial ownership of..
17/10/202314:44DJNAssembly Biosciences Shares Soar Premarket on Gilead Pact
17/10/202313:51DJNGilead Taking Stake in Assembly Bio Under Antiviral..
17/10/202313:10EDGAR2Form 8-K - Current report
17/10/202313:00BWGilead and Assembly Biosciences Establish Partnership to..
11/10/202314:00GLOBEAssembly Biosciences to Present New Data at AASLD The Liver..
04/10/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202301:20EDGAR2Form 144 - Report of proposed sale of securities
04/10/202301:18EDGAR2Form 144 - Report of proposed sale of securities
02/10/202314:00GLOBEAssembly Biosciences Nominates Development Candidate..
19/9/202322:05GLOBEAssembly Biosciences to Highlight Pipeline Progress in HBV..
19/9/202300:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/8/202322:28EDGAR2Form S-8 - Securities to be offered to employees in employee..
Apertura: 15,07 Min: 14,8082 Max: 15,40
Chiusura: 15,13

La tua Cronologia

NASDAQ
ASMB
Assembly Biosciences
BIT
F13769
Vontobel Financial Produ...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network